Moreover, an excess in mucin degradation has been linked to loss of host mucus homeostasis and metabolic disorders in mice and humans (reviewed in Tailford et al., 2015), that could potentially be linked with increased lipemia and hypertrophic adipocytes in captive VIMs (Aymen et al., 2022). Here, MUC5AC is linked to metabolic disease.